PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Hematology/Oncology, New York Presbyterian Hospital-Weill Cornell Medicine, New York, NY.\', \'Division of Hematology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.\', \'Department of Medicine and.\', \'Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.\', \'Platelet Disorder Support Association, Cleveland, OH.\', \'Division of Hematology, University of Washington, Seattle, WA.\', \'Division of Hematology/Oncology, Georgetown University Medical Center, Lombardi Comprehensive Cancer Center, Washington, DC.\', \'Division of Hematology/Oncology, University of California-San Francisco, San Francisco, CA.\', \'Division of Hematology, Yale School of Medicine, New Haven, CT.\', \'Jane Anne Nohl Division of Hematology, Department of Medicine, University of Southern California, Los Angeles, CA.\', \'Department of Haematology, Centre for Haematology, Barts and the London School of Medicine and Dentistry, London, United Kingdom.\', \'The Bleeding and Clotting Disorders Institute, Peoria, IL.\', \'Department of Medicine, University of Illinois College of Medicine-Peoria, Peoria, IL.\', \'Department of Haematology, Manchester University Hospitals, Manchester, United Kingdom; and.\', \'Division of Pediatric Hematology/Oncology, New York Presbyterian Hospital-Weill Cornell Medicine, New York, NY.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1182/blood.2021013411
?:hasPublicationType
?:journal
  • Blood
is ?:pmid of
?:pmid
?:pmid
  • 34587251
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.434
?:rankingScore_hIndex
  • 410
is ?:relation_isRelatedTo_publication of
?:title
  • SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all